Intrust Bank NA Has $493,000 Stock Holdings in Mettler-Toledo International, Inc. $MTD

Intrust Bank NA decreased its position in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 9.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 420 shares of the medical instruments supplier’s stock after selling 44 shares during the quarter. Intrust Bank NA’s holdings in Mettler-Toledo International were worth $493,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. Russell Investments Group Ltd. raised its stake in Mettler-Toledo International by 29.0% during the 1st quarter. Russell Investments Group Ltd. now owns 116,502 shares of the medical instruments supplier’s stock worth $137,548,000 after buying an additional 26,171 shares during the period. Tokio Marine Asset Management Co. Ltd. increased its holdings in shares of Mettler-Toledo International by 46.7% in the first quarter. Tokio Marine Asset Management Co. Ltd. now owns 7,829 shares of the medical instruments supplier’s stock worth $9,245,000 after acquiring an additional 2,493 shares in the last quarter. Legato Capital Management LLC raised its position in shares of Mettler-Toledo International by 107.7% during the first quarter. Legato Capital Management LLC now owns 2,050 shares of the medical instruments supplier’s stock worth $2,421,000 after purchasing an additional 1,063 shares during the period. Sound Income Strategies LLC lifted its holdings in shares of Mettler-Toledo International by 477.8% during the 2nd quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock valued at $61,000 after purchasing an additional 43 shares in the last quarter. Finally, LPL Financial LLC grew its position in shares of Mettler-Toledo International by 16.3% in the 1st quarter. LPL Financial LLC now owns 5,404 shares of the medical instruments supplier’s stock valued at $6,382,000 after purchasing an additional 758 shares during the period. Institutional investors own 95.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have commented on MTD. Wells Fargo & Company raised their target price on shares of Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Evercore ISI raised their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Stifel Nicolaus boosted their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a research report on Monday, November 10th. JPMorgan Chase & Co. increased their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a report on Thursday, October 9th. Finally, Citigroup lifted their price target on Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a research note on Monday, November 10th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat.com, Mettler-Toledo International has a consensus rating of “Hold” and a consensus target price of $1,406.50.

Insider Buying and Selling

In related news, CEO Patrick Kaltenbach sold 2,000 shares of the stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total transaction of $2,925,000.00. Following the completion of the transaction, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. This represents a 35.27% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Elisha W. Finney sold 474 shares of the business’s stock in a transaction that occurred on Monday, November 10th. The stock was sold at an average price of $1,433.57, for a total value of $679,512.18. Following the transaction, the director directly owned 311 shares in the company, valued at $445,840.27. This trade represents a 60.38% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 11,249 shares of company stock worth $16,338,723. Insiders own 1.94% of the company’s stock.

Mettler-Toledo International Trading Up 0.7%

Mettler-Toledo International stock opened at $1,398.50 on Wednesday. Mettler-Toledo International, Inc. has a 1-year low of $946.69 and a 1-year high of $1,471.06. The company has a fifty day simple moving average of $1,338.33 and a 200 day simple moving average of $1,255.33. The company has a market cap of $28.57 billion, a P/E ratio of 35.41, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41.

Mettler-Toledo International (NYSE:MTD) last issued its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping the consensus estimate of $10.62 by $0.53. The firm had revenue of $1.03 billion for the quarter, compared to analysts’ expectations of $997.36 million. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the firm posted $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. On average, equities research analysts forecast that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Mettler-Toledo International Company Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.